As a pharmaceutical company with many years of experience in manufacturing single-drug and combination tuberculosis treatments that meet stringent quality standards, Nam Ha Pharma is committed to providing stable, safe, and effective products, actively contributing to the treatment, control, and prevention of tuberculosis in Vietnam.

On May 7, 2026, Nam Ha Pharma was honored to accompany the Ceremony Commemorating the 117th Birthday of Dr. Pham Ngoc Thach, the Review Conference of the 2025 Tuberculosis Control Program, and the Implementation of the 2026 Plan organized by the National Lung Hospital in Hanoi.

The 2026 message: “Tuberculosis Detection Associated with Periodic Health Check-Ups for Every Citizen” continues to emphasize the importance of proactive screening, early detection, and timely treatment – key factors in the strategy to reduce the burden of tuberculosis.

By maintaining the supply of tuberculosis treatment medicines that meet strict quality standards, Nam Ha Pharma reaffirms its long-term commitment to accompanying the National Tuberculosis Control Program and contributing to the protection of community health.